We caught up with 2009 graduate Ying Su, Ph.D.:
Upon completion of my Ph.D., I moved to Boston for post-doctoral training at Dana-Farber Cancer Institute (DFCI). During my tenure at DFCI, I developed a strong sense that scientific insight is essential in the drug development process. Hence, I decided to pursue a career in translational medicine in the healthcare industry.
Currently, I head up the Translational Medicine department at Deciphera Pharmaceuticals, Inc. Deciphera is a clinical-stage biopharmaceutical company focused on addressing key mechanisms of tumor drug resistance. The Translational Medicine group provides scientific expertise to generate clinical development strategies including implementation of pharmacodynamic biomarkers indicating target engagement, hypothesis for patient enrichment and bringing clinical feedback back to discovery scientists.
I am grateful to have Dr. Rosie Simmen as my Ph.D. mentor and for all the training I have received at UAMS. It provided me with a solid foundation to pursue a fulfilling and rewarding career.
